Breaking News

Global Non-Therapeutic Antibiotics for Food Animals Market Report 2023: Market Segments, Size,Trend and Market projections for upcoming years


Global non-therapeutic antibiotics for food animals market size is expected to grow at a CAGR of 5.3% over the period of 2017–2023. Non-therapeutic antibiotics are administered at sub therapeutic levels in order to increase feed conversion rate. In order to have better margins livestock farmers administer the antibiotics in very low quantity through water especially in poultry and swine. Compound feed manufacturers and feed premix manufacturers are also adding antibiotics to make sure, their feed and ingredients give maximum profit to its buyers.

However, such practice has led to development of antibiotic resistant pathogens and hence are being banned in many countries and also controversy on its uses are increasing progressively. Thus the growth of antibiotics in many countries are being plateaued out and in others growth may prematurely can plateaued or even drastically fall.

Also Read:  Koinex introduces India’s first peer-to-peer platform for collateralized digital assets trading

Get Few Sample Pages of this Report:


Non-Therapeutic Antibiotics for Food Animals Market by Antibiotic Class

  • Medically Important
  • Non-Medically Important
  • Others

Non-Therapeutic Antibiotics for Food Animals Market by Route of Administration

  • Compound Feed
  • Feed Premix
  • Water
  • Feed Mixtures


Non-Therapeutic Antibiotics for Food Animals Market by Antibiotic Active Ingredient

  • Oxytetracyclines
  • Tylosin
  • Ampicillin and Amoxycillin
  • Gentamicin
  • Sulfaquinoxaline
  • Salinomycin
  • Bacitracin


For Make an Enquiry:   


Companies Covered in this Report:

  • AG Zoetis, Inc.
  • Boehringer Ingelheim GmbH
  • Eli Lilly and Company
  • Merck & Co., Inc.
  • Bayer AG
  • AG Sanofi
  • Ceva Sante Animale
  • Virbac
  • Vetoquinol S.A.
    • Dechra Pharmaceuticals


Go to website